G. Pillot

A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors

R. Govindan, P. Fracasso, R. Suresh, 2009, Chemotherapy.

Prognostic Value of Fluorodeoxyglucose Positron Emission Tomography in Non-small Cell Lung Cancer: A Review

R. Govindan, B. Siegel, G. Pillot, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognostic Value of Preoperative Positron Emission Tomography in Resected Stage I Non-small Cell Lung Cancer

F. Gao, R. Govindan, B. Meyers, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer.

R. Govindan, G. Pillot, A. Viswanathan, 2005, Lung cancer.

Response to bortezomib (velcade) in a case of advanced bronchiolo-alveolar carcinoma (BAC). A case report.

J. Subramanian, R. Govindan, V. Narra, 2006, Lung cancer.

A Phase II Study of Irinotecan and Carboplatin in Advanced Non-small Cell Lung Cancer with Pharmacogenomic Analysis: Final Report

R. Govindan, H. McLeod, W. Read, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Clinical Model to Estimate Recurrence Risk in Resected Stage I Non-Small Cell Lung Cancer

C. Miller, R. Govindan, J. Bradley, 2008, American journal of clinical oncology.

The role of docetaxel in N2 locally advanced non-small-cell lung cancer.

R. Govindan, G. Pillot, 2005, Clinical lung cancer.

The Washington manual hematology and oncology subspecialty consult

G. Pillot, 2004 .

Contents Vol. 55, 2009

Jianhua Shen, H. Kayed, J. Kleeff, 2009, Chemotherapy.